Controlled Substance Update

TO: All New York State Pharmacies

FROM: James Giglio, Director, Bureau of Narcotic Enforcement

DATE: September, 2006

SUBJECT: Controlled Substance Update

On August 16, 2006, a new law went into effect that made changes to the controlled substance schedules in section 3306 of the Public Health Law. The changes are summarized below. Where applicable, some common brand name pharmaceutical preparations containing the controlled substances are listed in bold:

Schedule II additions:

  • Remifentanil (ie;
  • Chlorotestosterone (4-Chlorotestosterone)
  • Dihydrotestosterone (4-Dihydrotestosterone;ie;
  • Methandienone
  • Methandranone
  • Testolactone (ie;

Schedule III additions:

  • Ketamine (ie;
  • Buprenorphine (ie;

Schedule IV additions:

  • Dichloralphenazone (ie;
  • Zaleplon (ie;
  • Zopiclone (Eszopiclone) (ie;
  • Modafanil (ie;
  • Sibutramine (ie;
  • Butorphanol (ie;

Schedule V

The new law made no additions to schedule V.